VIVALDI COELHO ROGERIO (President and CEO) received a stock award from SIGILON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/5/2021ACC: 0001415889-21-005084
DirectorOfficer· President and CEO
Since Dec 2020
+50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
213.1%
11/4/2021
23.46K→73.46K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/4/2021 | A · Award | +50K | — | — | 213.1% | 23.46K | 73.46K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported